J Barlinn1,2, K Barlinn3, U Helbig3, T Siepmann3,4, L-P Pallesen3, H Urban3, V Pütz3, J Schmitt5, H Reichmann3, U Bodechtel3. 1. Klinik und Poliklinik für Neurologie, Universitätsklinikum Carl Gustav Carus Dresden, Technische Universität Dresden, Fetscherstraße 74, 01307, Dresden, Deutschland. Jessica.Barlinn@uniklinikum-dresden.de. 2. Zentrum für Evidenzbasierte Gesundheitsversorgung, Universitätsklinikum Carl Gustav Carus Dresden, Technische Universität Dresden, Dresden, Deutschland. Jessica.Barlinn@uniklinikum-dresden.de. 3. Klinik und Poliklinik für Neurologie, Universitätsklinikum Carl Gustav Carus Dresden, Technische Universität Dresden, Fetscherstraße 74, 01307, Dresden, Deutschland. 4. Cardiovascular Clinical Research Facility, Radcliffe Department of Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK. 5. Zentrum für Evidenzbasierte Gesundheitsversorgung, Universitätsklinikum Carl Gustav Carus Dresden, Technische Universität Dresden, Dresden, Deutschland.
Abstract
BACKGROUND: Post-stroke care programs based on a standardized treatment pathway supported by case management may prevent secondary stroke and minimize risk factors. OBJECTIVES: We aimed to determine the feasibility of a standardized treatment pathway and its impact on risk factor control, life-style changes and adherence to secondary prevention medication. METHODS: We conducted a prospective pilot study in consecutive stroke patients. The 12-month post-stroke care program included regular perosnal and phone contact with a certified case manager. Target values for vascular risk factors following current recommendations of stroke guidelines were monitored and treated if necessary. In the case of deviations from the treatment pathway the case manager intervened. Patients were screened for recurrent stroke at the end of the program after 12 months. RESULTS: We enrolled 101 patients: 57.4 % were male, the median age was 72 (IQR, 62-80) years, median baseline NIHSS score was 2(IQR, 1-5), 79.2 % had an ischemic stroke, 3 % a hemorrhagic stroke, and 17.8 % a transient ischemic attack (TIA). Eighty-six (85.1 %) patients completed the program, 12 (11.9 %) withdrew from the program and 3 died of malignant diseases. In total, 628 personal (6.2/patient) and 2,683 phone contacts (26.6/patient) were conducted by the case manager. Three hundred-seventy-nine specific interventions were necessary mostly because of missing medication, non-compliance, and social needs. After 12 months, target goals for blood pressure, body mass index, nicotine use, and cholesterol were more frequently (p < 0.05) achieved than at baseline. No recurrent stroke occurred during the program. CONCLUSIONS: Our pilot data demonstrate that case management-based post-stroke care is feasible and may contribute to effective secondary prevention of stroke.
BACKGROUND: Post-stroke care programs based on a standardized treatment pathway supported by case management may prevent secondary stroke and minimize risk factors. OBJECTIVES: We aimed to determine the feasibility of a standardized treatment pathway and its impact on risk factor control, life-style changes and adherence to secondary prevention medication. METHODS: We conducted a prospective pilot study in consecutive strokepatients. The 12-month post-stroke care program included regular perosnal and phone contact with a certified case manager. Target values for vascular risk factors following current recommendations of stroke guidelines were monitored and treated if necessary. In the case of deviations from the treatment pathway the case manager intervened. Patients were screened for recurrent stroke at the end of the program after 12 months. RESULTS: We enrolled 101 patients: 57.4 % were male, the median age was 72 (IQR, 62-80) years, median baseline NIHSS score was 2(IQR, 1-5), 79.2 % had an ischemic stroke, 3 % a hemorrhagic stroke, and 17.8 % a transient ischemic attack (TIA). Eighty-six (85.1 %) patients completed the program, 12 (11.9 %) withdrew from the program and 3 died of malignant diseases. In total, 628 personal (6.2/patient) and 2,683 phone contacts (26.6/patient) were conducted by the case manager. Three hundred-seventy-nine specific interventions were necessary mostly because of missing medication, non-compliance, and social needs. After 12 months, target goals for blood pressure, body mass index, nicotine use, and cholesterol were more frequently (p < 0.05) achieved than at baseline. No recurrent stroke occurred during the program. CONCLUSIONS: Our pilot data demonstrate that case management-based post-stroke care is feasible and may contribute to effective secondary prevention of stroke.
Entities:
Keywords:
Case management; Post-stroke care; Secondary stroke prevention; Stroke
Authors: Alan S Go; Dariush Mozaffarian; Véronique L Roger; Emelia J Benjamin; Jarett D Berry; Michael J Blaha; Shifan Dai; Earl S Ford; Caroline S Fox; Sheila Franco; Heather J Fullerton; Cathleen Gillespie; Susan M Hailpern; John A Heit; Virginia J Howard; Mark D Huffman; Suzanne E Judd; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Rachel H Mackey; David J Magid; Gregory M Marcus; Ariane Marelli; David B Matchar; Darren K McGuire; Emile R Mohler; Claudia S Moy; Michael E Mussolino; Robert W Neumar; Graham Nichol; Dilip K Pandey; Nina P Paynter; Matthew J Reeves; Paul D Sorlie; Joel Stein; Amytis Towfighi; Tanya N Turan; Salim S Virani; Nathan D Wong; Daniel Woo; Melanie B Turner Journal: Circulation Date: 2013-12-18 Impact factor: 29.690
Authors: Peter L Kolominsky-Rabas; Peter U Heuschmann; Daniela Marschall; Martin Emmert; Nikoline Baltzer; Bernhard Neundörfer; Oliver Schöffski; Karl J Krobot Journal: Stroke Date: 2006-03-30 Impact factor: 7.914
Authors: Joachim Röther; Mark J Alberts; Emmanuel Touzé; Jean-Louis Mas; Michael D Hill; Patrik Michel; Deepak L Bhatt; Franz T Aichner; Shinya Goto; Masayasu Matsumoto; E Magnus Ohman; Yasushi Okada; Shinichiro Uchiyama; Ralph D'Agostino; Alan T Hirsch; Peter W F Wilson; P Gabriel Steg Journal: Cerebrovasc Dis Date: 2008-03-13 Impact factor: 2.762
Authors: E Bernd Ringelstein; Angel Chamorro; Markku Kaste; Peter Langhorne; Didier Leys; Philippe Lyrer; Vincent Thijs; Lars Thomassen; Danilo Toni Journal: Stroke Date: 2013-01-29 Impact factor: 7.914
Authors: Anna-Lotta Irewall; Lisa Bergström; Joachim Ogren; Katarina Laurell; Lars Söderström; Thomas Mooe Journal: Cerebrovasc Dis Extra Date: 2014-02-19
Authors: Rita V Krishnamurthi; Valery L Feigin; Mohammad H Forouzanfar; George A Mensah; Myles Connor; Derrick A Bennett; Andrew E Moran; Ralph L Sacco; Laurie M Anderson; Thomas Truelsen; Martin O'Donnell; Narayanaswamy Venketasubramanian; Suzanne Barker-Collo; Carlene M M Lawes; Wenzhi Wang; Yukito Shinohara; Emma Witt; Majid Ezzati; Mohsen Naghavi; Christopher Murray Journal: Lancet Glob Health Date: 2013-10-24 Impact factor: 26.763
Authors: Benjamin Hotter; Benno Ikenberg; Stephen Kaendler; Petra Knispel; Martin Ritter; Dirk Sander; Christopher Schwarzbach; Hans Joachim von Büdingen; Markus Wagner; Andreas Meisel Journal: Nervenarzt Date: 2021-12-21 Impact factor: 1.214
Authors: Stephen Kaendler; Martin Ritter; Dirk Sander; Matthias Elstner; Christopher Schwarzbach; Markus Wagner; Andreas Meisel Journal: Nervenarzt Date: 2022-01-03 Impact factor: 1.297
Authors: Sophie Lehnerer; Benjamin Hotter; Inken Padberg; Petra Knispel; Dike Remstedt; Andrea Liebenau; Ulrike Grittner; Ian Wellwood; Andreas Meisel Journal: BMC Neurol Date: 2019-09-06 Impact factor: 2.474